ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
2024年8月27日 - 5:05AM
ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage
oncology company focused on developing treatments that address
mechanisms of therapeutic resistance, today announced that
management will participate in the following investor conferences
in September:
- 2024 Wells Fargo Healthcare
Conference – Participating in a fireside chat on Thursday,
September 5, 2024, at 8:00 a.m. ET
- Baird 2024 Global Healthcare
Conference (Available to conference attendees only) –
Participating in a fireside chat on Tuesday, September 10, 2024, at
10:50 a.m. ET.
- 2024 Cantor Global
Healthcare Conference – Participating in a fireside chat
on Thursday, September 19, 2024, at 8:35 a.m. ET
Live webcasts of the Wells Fargo and Cantor
discussions will be available through the investor section of the
company’s website at www.oricpharma.com. Replays of the webcasts
will be available for 90 days following the events.
About ORIC Pharmaceuticals,
Inc. ORIC Pharmaceuticals is a clinical stage
biopharmaceutical company dedicated to improving patients’ lives
by Overcoming Resistance In Cancer. ORIC’s
clinical stage product candidates include (1) ORIC-114, a brain
penetrant inhibitor designed to selectively target EGFR and HER2
with high potency against exon 20 insertion mutations, being
developed across multiple genetically defined cancers, (2)
ORIC-944, an allosteric inhibitor of the polycomb repressive
complex 2 (PRC2) via the EED subunit, being developed for prostate
cancer, and (3) ORIC-533, an orally bioavailable small molecule
inhibitor of CD73, a key node in the adenosine pathway believed to
play a central role in resistance to chemotherapy- and
immunotherapy-based treatment regimens, being developed for
multiple myeloma. Beyond these three product candidates, ORIC® is
also developing multiple precision medicines targeting other
hallmark cancer resistance mechanisms. ORIC has offices in South
San Francisco and San Diego, California. For more information,
please go to www.oricpharma.com, and follow us
on X or LinkedIn.
Contact:Dominic Piscitelli,
Chief Financial
Officerdominic.piscitelli@oricpharma.cominfo@oricpharma.com
Oric Pharmaceuticals (NASDAQ:ORIC)
過去 株価チャート
から 11 2024 まで 12 2024
Oric Pharmaceuticals (NASDAQ:ORIC)
過去 株価チャート
から 12 2023 まで 12 2024